| |
| |
|
| Insider
Information: |
Hatfield Jeffrey S. |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
260,802 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
260,802 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vitae Pharmaceuticals, Inc |
VTAE |
Chief Executive Office... |
2016-10-24 |
244,996 |
|
0 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2023-05-22 |
15,806 |
2021-05-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,027 |
15,806 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2022-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,405 |
9,779 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2021-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,374 |
3,374 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Chief Executive Officer |
• • – |
2016-10-24 |
4 |
D |
$21.00 |
$5,144,916 |
D/D |
(244,996) |
244,996 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Chief Executive Officer |
• • – |
2016-04-29 |
4 |
A |
$6.11 |
$4,564 |
D/D |
747 |
294,996 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Chief Executive Officer |
• • – |
2015-12-28 |
4/A |
OE |
$3.45 |
$91,553 |
D/D |
26,537 |
294,249 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Chief Executive Officer |
• • – |
2015-12-28 |
4 |
OE |
$3.45 |
$91,553 |
D/D |
26,537 |
293,897 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Chief Executive Officer |
• • – |
2015-12-23 |
4 |
AS |
$17.00 |
$382,908 |
D/D |
(22,524) |
267,360 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Chief Executive Officer |
• • – |
2015-12-23 |
4 |
OE |
$3.45 |
$77,708 |
D/D |
22,524 |
289,884 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Chief Executive Officer |
• • – |
2015-03-13 |
4 |
D |
$11.16 |
$1,910,101 |
D/D |
(171,156) |
267,360 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Chief Executive Officer |
• • – |
2015-03-06 |
4 |
OE |
$1.15 |
$9,332 |
D/D |
8,115 |
438,516 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Chief Executive Officer |
• • – |
2015-01-22 |
4 |
OE |
$1.15 |
$44,962 |
D/D |
39,097 |
430,401 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Chief Executive OfficerOfficer |
• • – |
2014-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
391,304 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
